Evidence for Beneficial Associations between Isoenergetic Macronutrient Exchanges and Serum non-HDL Cholesterol, a Measure of All Circulating Atherogenic, apoB-Containing Lipoproteins.
作者信息
Griffin Bruce A, Lovegrove Julie A
机构信息
Department of Nutritional Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, United Kingdom.
Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading, Reading, Berkshire, United Kingdom.
出版信息
J Nutr. 2021 Aug 7;151(8):2096-2098. doi: 10.1093/jn/nxab127.
Abstract
摘要
相似文献
1
Evidence for Beneficial Associations between Isoenergetic Macronutrient Exchanges and Serum non-HDL Cholesterol, a Measure of All Circulating Atherogenic, apoB-Containing Lipoproteins.等能量常量营养素交换与血清非高密度脂蛋白胆固醇（一种衡量所有循环中致动脉粥样硬化的含载脂蛋白B脂蛋白的指标）之间有益关联的证据。
J Nutr. 2021 Aug 7;151(8):2096-2098. doi: 10.1093/jn/nxab127.
2
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?非高密度脂蛋白胆固醇还是载脂蛋白 B：预防动脉粥样硬化性心血管疾病，哪个指标更适合作为靶点？
Curr Cardiol Rep. 2020 Jun 19;22(8):67. doi: 10.1007/s11886-020-01323-z.
3
Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins.内皮脂肪酶促进含载脂蛋白B的脂蛋白的分解代谢。
Circ Res. 2004 Jun 25;94(12):1554-61. doi: 10.1161/01.RES.0000130657.00222.39. Epub 2004 Apr 29.
4
Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.确定含载脂蛋白B100的大、小脂蛋白的致动脉粥样硬化性。
J Clin Invest. 2000 Dec;106(12):1501-10. doi: 10.1172/JCI10695.
5
Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.肝脂酶在转基因小鼠中的过表达会降低含载脂蛋白B的脂蛋白和高密度脂蛋白。有证据表明肝脂酶作为脂蛋白摄取的配体发挥作用。
J Biol Chem. 1998 Jan 23;273(4):1896-903. doi: 10.1074/jbc.273.4.1896.
6
7
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.非高密度脂蛋白胆固醇和载脂蛋白B在男性冠心病预测中的作用
Circulation. 2005 Nov 29;112(22):3375-83. doi: 10.1161/CIRCULATIONAHA.104.532499.
8
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.载脂蛋白B/载脂蛋白A-I比值在评估血浆促动脉粥样硬化和抗动脉粥样硬化脂蛋白之间的平衡以及预测冠心病风险方面优于胆固醇比值。
Clin Chem Lab Med. 2004;42(12):1355-63. doi: 10.1515/CCLM.2004.254.
9
Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).强化他汀类药物治疗急性冠脉综合征（从限制 ACS 患者血脂治疗不足用瑞舒伐他汀的研究[LUNAR]）对致动脉粥样硬化脂蛋白胆固醇与载脂蛋白 B 比值的影响。
Am J Cardiol. 2013 Feb 15;111(4):506-9. doi: 10.1016/j.amjcard.2012.10.037. Epub 2012 Dec 10.
10
ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.载脂蛋白 B 与非高密度脂蛋白胆固醇：诊断与心血管风险管理。
Crit Rev Clin Lab Sci. 2013 Nov;50(6):163-71. doi: 10.3109/10408363.2013.847897.
本文引用的文献
1
Dietary Macronutrient Composition in Relation to Circulating HDL and Non-HDL Cholesterol: A Federated Individual-Level Analysis of Cross-Sectional Data from Adolescents and Adults in 8 European Studies.膳食宏量营养素组成与循环高密度脂蛋白和非高密度脂蛋白胆固醇的关系：来自8项欧洲研究的青少年和成年人横断面数据的联合个体水平分析。
J Nutr. 2021 Aug 7;151(8):2317-2329. doi: 10.1093/jn/nxab077.
2
Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes: a systematic review and meta-analysis.膳食脂肪摄入与 2 型糖尿病成人的心血管疾病风险：系统评价和荟萃分析。
Eur J Nutr. 2021 Sep;60(6):3355-3363. doi: 10.1007/s00394-021-02507-1. Epub 2021 Feb 21.
3
Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JACC State-of-the-Art Review.饱和脂肪与健康：重新评估与基于食物的推荐建议：JACC 现状评价综述。
J Am Coll Cardiol. 2020 Aug 18;76(7):844-857. doi: 10.1016/j.jacc.2020.05.077. Epub 2020 Jun 17.
4
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病：病理生理学、遗传学及治疗学见解：欧洲动脉粥样硬化学会共识小组的共识声明
Eur Heart J. 2020 Jun 21;41(24):2313-2330. doi: 10.1093/eurheartj/ehz962.
5
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM.量化致动脉粥样硬化脂蛋白以制定降脂策略：EAS 和 EFLM 的基于共识的建议。
Atherosclerosis. 2020 Feb;294:46-61. doi: 10.1016/j.atherosclerosis.2019.12.005. Epub 2020 Jan 9.
6
Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL.代谢紊乱中 HDL 代谢的改变：对 HDL 治疗潜力的深入了解。
Clin Sci (Lond). 2019 Nov 15;133(21):2221-2235. doi: 10.1042/CS20190873.
7
Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment.非高密度脂蛋白胆固醇和载脂蛋白 B 与 LDL 胆固醇在动脉粥样硬化性心血管疾病风险评估中的比较。
Pathology. 2019 Feb;51(2):148-154. doi: 10.1016/j.pathol.2018.11.006. Epub 2018 Dec 27.
8
Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles.富含饱和脂肪或 n-6 多不饱和脂肪酸并补充长链 n-3 多不饱和脂肪酸的饮食对血浆脂蛋白谱的影响。
Eur J Clin Nutr. 2017 Nov;71(11):1297-1302. doi: 10.1038/ejcn.2017.56. Epub 2017 May 10.
9
Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials.饱和脂肪、多不饱和脂肪、单不饱和脂肪及碳水化合物对葡萄糖-胰岛素稳态的影响：随机对照喂养试验的系统评价与荟萃分析
PLoS Med. 2016 Jul 19;13(7):e1002087. doi: 10.1371/journal.pmed.1002087. eCollection 2016 Jul.
10
Saturated Fats Compared With Unsaturated Fats and Sources of Carbohydrates in Relation to Risk of Coronary Heart Disease: A Prospective Cohort Study.饱和脂肪与不饱和脂肪及碳水化合物来源与冠心病风险的关系：一项前瞻性队列研究。
J Am Coll Cardiol. 2015 Oct 6;66(14):1538-1548. doi: 10.1016/j.jacc.2015.07.055.
Zotero 插件